Revising the WHO Essential Medicines List for paediatric rheumatology
Pediatr Rheumatol Online J
.
2021 Jan 23;19(1):10.
doi: 10.1186/s12969-021-00496-3.
Authors
Christiaan Scott
1
,
Nicola Smith
2
,
Rebecca James
3
,
Ben Whitehead
3
,
Rochelle Green
4
,
Helen E Foster
5
;
Paediatric Global MSK Task Force
Affiliations
1
Paediatric Rheumatology, University of Cape Town, Cape Town, South Africa.
2
Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.
3
Paediatric Rheumatology, Queensland Children's Hospital, Brisbane, Queensland, Australia.
4
Pharmacy, Queensland Children's Hospital, Brisbane, Queensland, Australia.
5
Population and Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK. h.e.foster@newcastle.ac.uk.
PMID:
33485334
PMCID:
PMC7824929
DOI:
10.1186/s12969-021-00496-3
No abstract available
Publication types
Letter
MeSH terms
Child
Drugs, Essential / therapeutic use*
Formularies as Topic
Humans
Pediatrics*
Rheumatic Diseases / drug therapy*
Rheumatology*
World Health Organization*
Substances
Drugs, Essential